# Elicio Therapeutics, Inc.: Form SC 13D/A, filed Jul 2, 2024

- Company: [Elicio Therapeutics, Inc.](/companies/eltx.md) (CIK 1601485)
- Form: SC 13D/A
- Filed: 2024-07-02
- Accepted by EDGAR: Jul 2, 2024, 16:39 ET
- Period: not reported
- Accession: 0001068238-24-000141
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1601485/000106823824000141/gkcc_sch13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1601485/000106823824000141/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1601485/000106823824000141/gkcc_sch13da.htm

Filed Jul 2, 2024.
Source: SEC EDGAR, the filing index for accession 0001068238-24-000141. Last ingested by Listed: Nov 5, 2026, 17:56 ET. No prices; not investment advice.